Kristian Reich

ORCID：0000-0001-5248-4332

发表论文 738 篇 · 总被引 43902 次 · h-index 106

代表论文

• Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape (2023 · British Journal of Dermatology · 被引 109)
• Targeting IL ‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years (2024 · Allergy · 被引 63)
• Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis (2024 · JAMA Dermatology · 被引 61)
• Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis (2024 · JAMA Dermatology · 被引 54)
• Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study (2023 · Journal of the European Academy of Dermatology and Venereology · 被引 52)
• Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study (2023 · The Lancet Rheumatology · 被引 31)